2013 International Conference on Diabetes and Metabolism

> Home > Scientific program

OM1 Current status of bariatric surgery in Asia (AASD)

Thursday, 7 November 10:20~11:50 / Emerald hall A
Chair: Wenying Yang


	Go Wakabayashi Iwate Medical University, Japan		OM1-1 Current status of bariatric surgery in Asia
	Kyung-Yul Hur Soonchunhyang University, Korea		OM1-2 Bariatric to metabolic surgery
	Enders Kwok-wai Ng The Chinese University of Hong Kong		OM1-3 Use of bariatric surgery in treating type II diabetes mellitus: experience in Hong Kong

OM2 Pathogenesis in non-alcholic steatohepatitis (ICDM)

Thursday, 7 November 16:00~17:30 / Emerald hall A
Chair: Bong Soo Cha


	Cheol-Young Park Sungkyunkwan University, Korea		OM2-1 Role of NPC1L1 (niemann-pick C1-like 1) in preventing hepatic steatosis
	Eun Hee Koh University of Ulsan, Korea		OM2-2 Novel regulators in the development of non-alcholic steatohepatitis
	Jose C. Ferenandez-Checa Institute of Biomedical Research of Barcelona, Spain		OM2-3 Cholesterol and sphingolipids in nonalcoholic fatty liver disease

OM3 Hypothalamic regulation of obesity (ICDM & AASD)

Friday, 8 November 09:00~10:30 / Emerald hall A
Chair: Min Seon Kim


	Ja-Hyun Baik Korea University, Korea		OM3-1 Hypothalamic melanocortin receptor 4 signaling in control of obesity
	Ki Woo Kim Yonsei University, Korea		OM3-2 CNS-mediated control of energy and mental homeostasis; functional roles of SF-1 in the VMH
	Toshiyasu Sasaoka University of Toyama, Japan		OM3-3 Role of orexin in the hypothalamic regulation of energy homeostasis

OM4 Lipid metabolites and metabolism (ICDM)

Friday, 8 November 15:00~16:30 / Emerald hall A
Chair: Ki-Up Lee


	Hyun Joo Yoo University of Ulsan, Korea		OM4-1 Application of bioactive phospholipid profiling: with an emphasis on low level lipids
	Tae-Sik Park Gachon University, Korea		OM4-2 Regulation of hepatic glucose and fatty acid metabolism by sphingosine 1-phosphate
	Xian-Cheng Jiang SUNY Downstate Medical Center, USA		OM4-3 Deficiency in sphingolipid de novo synthesis impairs cell polarity

OM5 Update of obesity treatment (ICDM)

Saturday, 9 November 09:00~10:30 / Emerald hall A
Chair: Jeong Taek Woo


	Sung Rae Kim The Catholic University, Korea		OM5-1 Lorcaserin, a novel serotonin 2C agonist for the treatment of obesity
	Seung Joon Oh Kyung Hee University, Korea		OM5-2 Revival of old drugs: phentermine/topiramate combination
	Won Jun Kim University of Ulsan, Korea		OM5-3 New therapies to induce brown adipose tissue